Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Kevelleon Dec 21, 2017 8:50pm
214 Views
Post# 27211287

RE:TGIF flew. MGW will be next.

RE:TGIF flew. MGW will be next.Same here. In ACB at $2.05... stalled... Market is waiting for the outcome of the CMED deal.  ACB will rocket with a positive outcome.  Long on N, TGIF, TNY, TBP, and RTI.  Most recent acquisition: ABCN.   

While access to capital and licensing could become a major constraint for smaller cannabis companies, Cannabis Wheaton's flexible royalty model will allow it to become profitable much faster than the competition as production increases.

Recent catalysts for the company's future prospects include a $15 million purchase of shares in ABcann Global Corporation (ABcann) in August, which forms part of a larger investment into ABcann that will add 50,000 square feet of acreage to ABcann's cultivation facility. Another $15 million purchase of ABcann shares is scheduled for next year, with half of the production revenues of such 50,000 square foot expansion going to CBW.

ABcann could become a major supplier to CBW in the future, as it brings this new capacity on-line. With a planned for margin of $4.5/gram, that could translate into a 70 percent internal rate of return.

The company's CEO Chuck Rifici co-founded Canopy Growth Corp. (formerly Tweed Marijuana Inc.) which has a current market cap of over $3.7 billion and now he looks to do the same with Cannabis Wheaton. There is strong political support for CBW's unique business model, which could prevent a major supply deficit in cannabis once it becomes legal for recreational use in 2018.

With support like this, a strong model and high potential for immense growth once legalization takes off, Cannabis Wheaton and ABcann are definitely cannabis stocks to watch.

Bullboard Posts